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Summary. Thirty-six lung adenomata induced in mice by urethane followed or
not by cortisone, all had an adenomatous morphology at the first s.c. transplant
in syngeneic hosts. Seventeen of them acquired a sarcomatous structure within
a few s.c. transplant generations whilst the other 19 remained adenomatous for
as long as tested, i.e. at least 10 transplant generations. The change of morphology
was not dependent on s.c. growth, since tumours also transformed when allowed
to grow in the lung, and was not correlated to the capacity of a tumour for growth
or metastasis. The 2 types of tumours were antigenically different, since only
tumours that after few transplants changed their morphology were found at the
first s.c. transplant to possess tumour-associated membrane antigens as revealed
by an in vitro test. In addition, only the tumours which acquired a sarcomatous
morphology were found gs-positive. The majority of antigenic primary tumours
arose in mice belonging to the groups of treatment which induced the strongest
immunodepression. It is suggested that a predisposition to sarcoma progression
is related to an immunological control, at the time of adenoma induction, of an
oncornavirus, responsible for the superimposed sarcomatous change.
SPONTANEOUS or chemically induced
primary murine lung adenomata are
histologically similar, having a glandular
pattern with cells arranged in acini and
often disposed in papillary formations.
During successive trannsplant generations
in syngeneic hosts the tumours grow
progressively faster and some of them
change from the adenomatous to a
sarcomatous pattern (Stewart et al., 1947;
Stewart, 1959). C-type virus particles
for which no oncogenic role in lung adeno-
magenesis has been demonstrated, have
been observed in spontaneous or chemic-
ally induced murine lung adenomata and
been seen to increase during transplanta-
tion (Bucciar-elli, 1971; Bucciarelli and
Ribacchi, 1972; Kimura et al., 1972).
The aim of the present experiment
was to establish whether the change in
morphological structure of urethane-
induced lung adenomata during trans-
plantation is correlated with certain
tumour characteristics such as malignancy,
evaluated as capacity for growth or
metastasis, or presence of tumour-asso-
ciated cell-surface antigens or viral anti-
gens. Having previously demonstrated
(Colnaghi et al., 1971; Menard et al.,
1973) that lung adenoma antigenicity
was directly correlated with the treatment-
induced immunological impairment of the
primary host, we now report on the
influence of this impairment on the
proneness of the morphological structure
to modify during transplantation.
MATERIALS AND METHODS
Animals.-Inbred BALB/c mice and the
(C3Hf x BALB/c)F1 hybrids of both sexes,
maintained in this laboratory, were used.
Tumours.-Lung adenomata were in-
duced by 5 i.p. injections of urethane 0-2
or 1 mg/g body weight once every second
day in BALB/c mice, starting at 10 days
of age (Group A and B). Two other groupsANTIGENICITY AND MORPHOLOGY OF MURINE LUNG ADENOMATA
of mice (C and D) received the same urethane
treatments and in addition, on alternate
days, 5 injections of 01 mg/g body weight
of cortisone. In a previous paper, it was
reported that the 4 types of treatment caused
an increasing immunological impairment,
evaluated by the Jerne technique, from
Group A to D, and that the antigenicity
of the lung adenomata was inversely related
to the immunodepression of the tumour host
(Menard et al., 1973). The mice were
killed when they showed dyspnoea, the
adenomatous nodules were dissected from
the normal tissue and a cell suspension was
mechanically prepared in Hanks' balanced
salt solution (HBSS). The cells were then
used for in vivo transplantation or were
grown in vitro for the cytotoxicity test.
In vivo studies.-The tumours wN-ere
maintained in vivo by s.c. or i.v. inoculation
of 0-2 ml of the cell suspension, containing
about 1 x 106 cells, prepared from the
primary lung adenomata or from the s.c.
transplants or from pulmonary nodules.
The s.e. inoculum was into the right flank
and the i.v. into the tail vein of syngeneic
mice of the same sex as the tumour donor.
The animals ere killed for tumour
morphology examination and subsequent
transplantation when the tumours reached
10 x 10 mm in diameter or when, after the
i.v. inoculation, mice presented dyspnoea.
Cytotoxicity test.-The cell suspension,
obtained as described, was centrifuged and
the cells were suspended in medium 199
supplemented with 20% foetal calf serum,
100 i.u./ml penicillin and 50 Hg/ml strepto-
mycin. The cells were seeded directly in
tissue culture plastic microplates (No. 3034
Falcon Plastics, Los Angeles, Calif.) with
60 wells of 10 ,tl each, into which were
delivered 500 viable tumour cells in 10 ,ul
medium. The microplates were incubated
at 37°C in a 5% CO2 humidified atmosphere
and 4 days later the medium was renewed
and the plates were incubated for a further
3 days. Then the microplates were washed
and 5 x 104 viable lymphocytes in 10 ,ul
medium were delivered into each well in
which 300-500 tumour target cells were
found. After 48 h incubation the micro-
plates were washed carefully with HBSS
to remove lymphoid and dead cells and
viable attached cells were fixed in methanol
and stained with May-Griinwald-Giemsa.
Counting was carried out under the micro-
scope with the help of a 25-square grid
covering the entire floor of the well except
the margins, and taking into consideration
only epithelial-like cells present in 10 squares
per well. The significance of the difference
between the adenoma cell number after
exposure to experimental or control effector
cells was evaluated by Student's t test.
Differences were considered significant when
P was 0-01 or less.
Lymphocytes. 2-3 month old BALB/c
mice of the same sex as the tumour donors
were injected s.c. with 0-2 ml HBSS con-
taining 1 x 106 living cells from the cell
suspension of BALB/c transplanted adeno-
mata. The subcutaneous tumours, grown
to about 10 mm in diameter, were surgically
removed and 10 days afterwards effector
cells were obtained by purification with
Ficoll-Triosil method from spleen of tumour-
or sham-operated animals.
Determination of the gs antigen. Cell
suspensions in HBSS from transplanted
lung adenomata were prepared. The cells
were packed by centrifugation, resuspended
in distilled water for 20 min, homogenized
at 4°C at about 14,000 rev/min and centri-
fuged at 100,000 g for 1 h. The super-
natants were preserved and the pellets were
added with 20 volumes of peroxide-free
ether and shaken for 2 h. The ether was
then removed by cold N2 and the ether-
treated extracts were mixed each with its
own supernatant and centrifuged at 100,000 g
for 1 h. The pellets were discarded, and
the supernatants dialysed against distilled
water, lyophilized, resuspended in a volume
of HBSS reduced to approximately one-
fifth the initial tissue weight and then tested
in doubling dilutions by the double diffusion
test with a rat antiserum having a pre-
cipitating activity for gs antigen.
Histology.-Fragments of primary and
transplanted lung adenomata were prepared
for light microscopy, the tissues being
fixed in Bouin solution. Paraffin sections
were stained by haematoxylin and eosin.
RESULTS
Changes in morphology
Thirty-six BALB/c primary lung ade-
nomata, equally distributed for their
origin from the four treatment groups,
and their successive transplants, were
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histologically examined. All the primary
tumours presented an adenomatous struc-
ture and grew slowly when transplanted
s.c. into a syngeneic host, reaching a
size of about 10 x 10 mm diameter in
a mean time of 112 ± 10 days. Often
the tumour-bearing animals were still
alive 1 year after inoculation. During
the subsequent transplants all the tumours
grew progressively faster: 17 of them
changed into sarcomata by the 5th trans-
plant, whereas the other 19 retained
their initial adenomatous morphology at
the 10th transplant generation (Fig. 1).
In most instances the morphological
modification was abrupt, although on
several occasions admixtures of glandular
structures and a solid growth resembling
sarcoma were observed (Fig. 2, 3 and 4).
Five of the 19 tumours which were found
to retain the adenomatous morphology
at the 10th passage, were studied also at
subsequent transplants and no changes
in morphology were noted (Fig. 5).
To exclude the possibility that the
sarcomatous change was due to a recruit-
ment of mesenchymal host cells from
the fibrous capsule surrounding tumours,
a primary adenoma from the most
immunodepressed group of treatment (D)
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FIG. 1. Change of morphology of 36 lung
adenomata during serial s.c. transplants.
FIG. 2. Typical adenomatous structure of a lung adenoma at the 1st s.c. transplant. x 150.
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FIG. 3.-A transition form between adenomatous and sarcomatous morphology at the 2nd s.c.
transplant. x 375.
Fie. 4.-Sarcomatous structure of a lung adenoma at the 8th s.c. transplant. x 375.
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FIG. 5.-Adenomatous structure of a lung adenoma at the 12th s.c. transplant.
was serially transplanted s.c. in hybrid
(C3Hf x BALB/c)Fj mice, where at the
3rd transplant generation it acquired
a sarcomatous structure. The tumour
was retransferred into the 2 parental
strains, C3Hf and BALB/c, at the 1st,
3rd, and 5th transplant, and was found
to grow in BALB/c mice only (Table I).
To rule out a possible role of the
subcutaneous location of the tumour
transplants, another primary adenoma
of Group D was serially injected as
w-ell into the tail vein so that the adeno-
matous cells could reach the lung and
grow in their original milieu. The tumour
acquired a sarcomatous morphology with
both techniques, at the 3rd passage when
transplanted s.c. and at the 4th passage
TABLE I. Growth of a BALB/c Lung Adenoma in (C3Hf x BALB/c)Fl Hybrids and
Subsequent Transfer in the Parental Mice
Tumour growth in
(C3Hf x BALB/c)F,
No. of days to
Tumour a 10 x 10 mm
take* tumourt Morphology
4/4 40 adenoma
2/3 47 adenoma
4/4 25 sarcoma
4/4 20 sarcoma
4/4 19 sarcoma
Transfer in
, K A~~~~~~
C3Hf
Tumour
take*
0/4
NT:
0/4
NT:
0/4
BALB/c
, K o~~~~
Tumour
take*
4/4
NTT
3/3
NTT
4/4
No. of days to
a 10 x 10mm
tumourt
42
Morphology
adenoma
25 sarcoma
20 sarcoma
* No. of mice with tumour/No. of transplanted mice.
t Mean value for the growing tumours.
t Not tested.
Tranaplant
generation
1
2
3
4
5
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when growing in the lung. The tumour
cells injected i.v. originated numerous
small nodules in all lobes.
Growth and metastasis characteristics
The subcutaneous growth of 5 lung
adenomata which did not change their
morphology after serial passages and
of 8 which transformed into sarcomata,
was evaluated from the 1st through the
8th transplant generation. As shown in
Fig. 6, tumour growth, expressed as the
time taken to reach a 10 x 10 mm
diameter, was accelerated in the successive
transplants for both tumour types, though
the sarcomatous tumours grew more
rapidly then the adenomatous ones.
Six tumours, 3 adenomatous and 3
sarcomatous, were also studied at various
transplant generations for their ability
to give rise to lung metastases, within
2, 4. 6 or 8 weeks after s.c. implantation.
The mice came under observation either
on spontaneous death or on sacrifice
when moribund or at the time scheduled
for killing. Since no differences were
noted at the different transplants, the
data for each tumour were pooled (Table
II). Two sarcomatous tumours killed
the host before the 6th or the 8th week
with only 1 case of lung metastases,
death being ascribed to the huge s.c.
growth. One sarcomatous and 2 adeno-
matous tumours gave pulmonary meta-
stases, the former earlier and at a higher
rate than the latter. The animals im-
planted with the 3rd adenomatous tumour
did not develop metastases.
=
a 1 o
I--
E E
a
x
0
O 5_
o
z
1
1 2 3 4 5 6
TRANSPLANT GENERATION
7 8
FIG. 6. Relationship between morphology
and growth rate of lung tumours during
s.c. transplantation: O EZ adeno-
matous, * * sarcomatous tumours.
Correlation between antigenicity and subse-
quent morphology
Nine lung adenomata were tested at
the first transplant, when all were adeno-
matous, for membrane antigenicity by
an in vitro microtest for cell-mediated
immunity. Five tumours were destroyed
by lymphocytes immune against a syn-
geneic lung adenoma previously demon-
strated immunogenic, and all of them
acquired the sarcomatous morphology
during the subsequent transplants. Four
tumours were negative for membrane
antigenicity and all of them maintained
the adenomatous appearance permanently
(Table III). Eleven tumours were tested
by immunodiffusion for the presence of
TABLE II. Capability of Adenomatous and Sarcomatous s.c. Tumours to Give Rise to
Lung Metastases
Animals with lung metastases/Total
4 weeks
2/18
1/20
0/26
0/14
0/16
0/10
6 weeks
17/19
no survivors
0/6
0/10
0/9
0/9
8 weeks
no survivors
no survivors
no survivors
2/14
0/9
3/10
No. of
mice
42
32
36
38
37
29
Tumour
type
sarcoma
sarcoma
sarcoma
adenoma
adenoma
adenoma
Treatment
group
C
C
B
B
A
C
Transplant
generation
8-15
10-20
9-17
6-12
12-17
14-17
* Not tested.
2 weeks
0/5
0/12
0/4
NT*
0/3
NT*
I ---r
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TABLE III.-Relationship Between Morphology and Antigenicity of 12 Lung Adenomata*
Tumours
Ad 1
Ad 14
Ad 18
Ad 24
Ad 26
Ad 44
Ad 62
Ad 29
Ad 35
Ad 36
Ad 50
Ad 54
Treatment
group
D
C
C
A
B
B
D
B
A
A
B
C
Final
morphology
sarcoma
sarcoma
sarcoma
sarcoma
sarcoma
sarcoma
sarcoma
adenoma
adenoma
adenoma
adenoma
adenoma
No. ofcells remaining after incubation
with lymphocytes ± SE
Immune
38±9
134±9
NT:
122± 10
NT:
55±6
114±8
93±13
124±16
32±5
NT.
116±9
Normal
74±13
213±12
NT:
187± 13
NT:
114±19
224± 11
87±10
137±12
36±6
NTt
122±9
% reduction
49t
38t
35t
52t
49t
+7
10
12
5
gs antigen
+
+
NT4t
+
+
* The cytotoxicity test was done on tumours at the first transplant, the gs test on transplanted tumours
when they had reached the definitive morphology.
tP < 0.05.
: Not tested.
the gs antigen when they had acquired the
final morphology; 5 out of 6 sarcomatous
tumours tested were positive at dilutions
ranging between 1: 32 and 1:128 whereas
all 5 adenomatous ones were negative,
even when tested undiluted (Table III).
Correlation between immunological status of
theprimary host and subsequent morphology
The 36 lung adenomata used in the
present study were originally induced in
4 groups of mice with 4 different carcino-
genic schedules of treatment which had
a different immunodepressive effect, and
their antigenicity as primary tumours
correlated directly with the immune status
ofthe host, i.e. the more immunodepressed
hosts originated the more antigenic tu-
mours (Colnaghi et al., 1971; Menard et
al., 1973). As shown in Fig. 7, we now
report a correlation between the immuno-
logical status of the original host and the
proneness of the tumours to change
morphology, since almost all the tumours
that arose in the most immunodepressed
group became sarcomatous, whereas about
75% of the tumours arising in the less
immunodepressed group remained adeno-
matous.
DISCUSSION
The change of morphology of lung
adenomata during successive transplant
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FIG. 7. Relationship between immunode-
pression of the primary tumour host,
evaluated by the Jerne technique, and the
proneness of 36 lung adenomata to become
sarcomatous after 7 transplant generations.
8-12 tumours per group of treatment: A
and B, low and high dose of urethane,
C and D, urethane plus cortisone.
generations is an already reported but
unexplained phenomenon, occurring in
about 50% of the transplanted tumours
(Stewart, 1959). We studied various para-
meters of this phenomenon and the
results suggest that the progression from
a glandular to a sarcomatous pattern is
not a random but a predetermined event.
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adenomatous at the first transplant when
they grew slowly, in general without
killing the host. We found that, upon
serial transplantation, some tumours
changed their histologic morphology with-
in a few transplants, becoming sarcoma-
tous, whilst others retained their original
adenomatous structure for as long as
tested. The change of morphology does
not seem to be influenced by the s.c.
growth of the transplanted tumours,
since the adenomata which eventually
became sarcomatous after s.c. trans-
plants, transformed also when allowed
to grow in the lung. We can exclude
a recruitment of mesenchymal host cells
since a BALB/c lung adenoma trans-
planted in F1 hybrids and then retrans-
ferred in the 2 parental strains, still grew
well in the BALB/c host.
The difference in morphology was
only partially correlated with the capacity
of the tumours for growth or metastasis
assumed as indicators of malignancy.
The 2 morphologically different types
of lung tumours in fact both increased
their growth capacity in the successive
transplants, although the sarcomatous
tumours grew more rapidly than the
adenomatous ones. Both types had the
capacity to metastasize but the sarco-
matous tumours metastasized more
rapidly.
The immunological behaviour of the
2 types of tumour differed, since only
tumours that changed their morphology
after the first few transplants were found
to possess tumour-associated membrane
antigens at the first transplant. This
antigenicity was conditioned by the im-
mune responsiveness of the primary tu-
mour host, since the majority of the
antigenic adenomata were observed in
the most immunodepressed groups, and
seems to be related to a C-type oncorna-
virus, since a mouse anti-G serum was
completely absorbed by antigenic adeno-
mata (unpublished results). Moreover,
only sarcomatous tumours were gs-posi-
tive, at least as revealed by the sensi-
tivity of the assay we used.
It therefore appears that adenomata
destined to become sarcomatous are
somehow related to a viral activity. A-
and C-type particles have been described
in primary lung adenomata and it has
been reported that A-particles disappeared
upon transplantation whereas C-particles
increased (Bucciarelli and Ribacchi, 1972).
We suggest that a predisposition to
sarcoma progression is related to a com-
plex immunological control at the time
of adenoma induction that conditions
the activity of an oncorna virus which,
although perhaps without an etiological
role in adenomagenesis, is nonetheless
responsible for the superimposed sarco-
matous change of tumours occurring in
immunodepressed animals. The change
does not take place when the immune
system of the primary tumour host can
control the virus, either by modulating
its antigenic expression, as already re-
ported for cellular and viral antigens
(Boyse et al., 1967; Joachim et al., 1972),
or by eliminating the antigenic cells.
This work was in part supported by
a research grant from the Consiglio
Nazionale delle Ricerche, Rome.
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